Normal rapid eye movement sleep involves skeletal muscle paralysis that prevents dream enactment. However, the loss of this motor suppression produces REM sleep without atonia, a primary neurophysiological marker for sleep-related movement disorders. Although clinicians frequently associate motor tone disruption with neurodegeneration, true baseline prevalence data in healthy populations have remained sparse. Consequently, recent population-based polysomnographic analyses provide essential epidemiological clarity for clinicians worldwide.

Understanding REM Sleep Without Atonia in Population Health

Motor atonia during rapid eye movement sleep protects individuals from executing physical actions while dreaming. Specifically, pontine and medullary neural networks hyperpolarize spinal motor neurons during this physiological stage. When neurodegenerative changes or pharmacological agents damage these descending inhibitory pathways, motor tone reappears. Clinicians recognize this phenomenon as a key feature of REM sleep behavior disorder. Furthermore, research indicates that subclinical motor activity often precedes overt dream enactment behaviors by several years or decades. In routine clinical practice, sleep laboratories typically evaluate symptomatic individuals who present with sleep disruption or violent motor episodes. As a result, selection bias has historically obscured the baseline frequency of uninhibited motor activity in community-dwelling adults. The São Paulo Epidemiologic Sleep Study, known as EPISONO, provides critical objective insight into this baseline prevalence. By evaluating a representative non-clinical sample, the investigators established normative parameters that assist clinicians in distinguishing incidental motor tone from progressive neuropathology. Consequently, these epidemiologic benchmarks allow practitioners to interpret polysomnographic anomalies with greater diagnostic precision.

Methodology and Electromyographic Metrics in the EPISONO Cohort

The fourth edition of the EPISONO project evaluated community adults between 2018 and 2019 in São Paulo, Brazil. Researchers performed standard type-I in-laboratory polysomnography on all participants under controlled conditions. In addition, the research protocol incorporated bilateral surface electromyography of the flexor digitorum superficialis muscles of the upper limbs. Investigators specifically quantified phasic muscle activity across standard thirty-second REM epochs subdivided into smaller three-second mini-epochs. They defined a positive epoch as one containing at least five mini-epochs with distinct muscle twitch bursts. Subsequently, an index threshold of 7.7% identified cases of possible motor disinhibition. Crucially, the analytical model corrected raw measurements against diagnostic specificity values derived from REM-specific apnea-hypopnea indices. Obstructive respiratory events can simulate transient motor activation during sleep; therefore, this adjustment prevented false-positive classifications caused by sleep-disordered breathing. Furthermore, the rigorous sampling strategy ensured that the cohort mirrored the demographic and socioeconomic structure of the general urban population. In this manner, the technical methodology established robust, reproducible thresholds for clinical electrophysiology and population-level sleep research.

Key Epidemiologic Findings and Gender Disparities Across Age Groups

The investigation revealed an adjusted general population prevalence of 8.24% for possible motor disinhibition during dream sleep. Interestingly, younger and middle-aged adults demonstrated virtually identical rates across biological sexes. Both men and women under sixty years exhibited comparable, relatively modest baseline levels of muscle tone escape. However, a striking divergence emerged among older demographics. Specifically, men aged sixty years and older displayed a substantial surge in motor activation during REM stages. In contrast, older women maintained stable prevalence rates that aligned closely with younger cohorts. This male predominance in older adults mirrors the well-documented epidemiological patterns observed in confirmed REM sleep behavior disorder. Clinical data consistently report that older males develop idiopathic parasomnias at significantly higher rates than older females. Consequently, these findings indicate that physiological control of dream-stage motor inhibition declines selectively in aging males. Moreover, the high overall prevalence suggests that isolated motor activity during REM sleep occurs far more frequently in non-clinical communities than previous retrospective studies estimated. Therefore, clinicians must avoid overinterpreting incidental findings in older patients while remaining vigilant for progressive neurodegenerative symptoms.

Clinical Implications for Alpha-Synucleinopathy Risk Stratification

From a pathophysiological standpoint, persistent loss of REM atonia represents a robust prodromal marker for alpha-synucleinopathies. Conditions such as Parkinson disease, dementia with Lewy bodies, and multiple system atrophy frequently manifest dream sleep abnormalities decades before overt parkinsonism appears. Therefore, detecting motor tone disinhibition in non-clinical populations raises vital questions regarding early disease screening. However, clinicians must recognize that an isolated 8.24% prevalence exceeds the projected lifetime risk of neurodegenerative disorders in the general public. This discrepancy proves that not every individual exhibiting elevated muscle tone will inevitably convert to a clinical synucleinopathy. In many cases, isolated electromyographic elevations represent benign age-related alterations or secondary medication effects. For instance, serotonergic antidepressants and other neuroactive compounds frequently induce transient motor activation during REM sleep. Nonetheless, the selective escalation of muscle tone in older men reinforces shared vulnerability pathways. Clinicians evaluating patients with polysomnographic anomalies should therefore perform thorough assessments for subtle non-motor symptoms, including constipation, hyposmia, cognitive fluctuations, and autonomic instability. Furthermore, longitudinal monitoring allows clinicians to distinguish benign physiological fluctuations from emerging prodromal neurodegeneration in vulnerable individuals.

Practical Considerations for Sleep Medicine Specialists and Neurologists

When evaluating polysomnographic data, sleep physicians frequently observe incidental muscle twitches during REM sleep. Because automated scoring algorithms vary across software platforms, practitioners must visually confirm electromyographic activity in the flexor digitorum superficialis and mentalis leads. Moreover, clinicians must carefully rule out artifactual signals caused by limb movements, snoring vibrations, or brief cortical arousals. If the physician confirms elevated motor tone, a detailed clinical history becomes essential. Specifically, clinicians should query both the patient and bed partner regarding vocalizations, flailing movements, or injurious dream reenactment. Additionally, reviewing the patient's medication schedule helps identify offending pharmaceuticals such as selective serotonin reuptake inhibitors. In the absence of clinical dream enactment, physicians should avoid causing unnecessary anxiety about neurodegeneration. Instead, practicing neurologists recommend periodic clinical follow-up without aggressive pharmacological intervention. For patients who exhibit progressive motor behaviors, safety counseling regarding the sleeping environment represents the primary management priority. Consequently, clear communication helps patients understand their findings while preserving clinical vigilance for progressive neurological conditions. Thus, an integrated approach combining objective electrophysiology with thoughtful clinical assessment optimizes patient outcomes and prevents unwarranted diagnostic alarm.

What causes REM sleep without atonia?

REM sleep without atonia occurs when neural pathways in the brainstem fail to inhibit spinal motor neurons during dream sleep. While structural neurodegeneration associated with alpha-synucleinopathies represents a major cause in older adults, secondary factors such as antidepressant medications, narcolepsy, and severe obstructive sleep apnea also frequently trigger this phenomenon.

How does REM sleep without atonia differ from REM sleep behavior disorder?

REM sleep without atonia is an objective polysomnographic finding defined by elevated muscle tone during REM sleep. In contrast, REM sleep behavior disorder requires both this electromyographic abnormality and a documented clinical history of dream enactment behaviors, such as shouting, punching, or thrashing, which can potentially cause injury.

Should asymptomatic patients with this finding receive neurological treatment?

Asymptomatic patients discovered to have isolated muscle tone during REM sleep do not require pharmacotherapy. Instead, clinicians advise regular longitudinal monitoring, bedroom safety precautions, and screening for early non-motor features of synucleinopathies. Physicians should also review and adjust medications that promote motor disinhibition before considering any further diagnostic interventions.

Disclaimer: This content is for informational and educational purposes only and should not be considered medical advice. Healthcare professionals must exercise independent clinical judgment. Refer to the latest local and national guidelines for clinical practice.

References

1. Pires GN et al. Prevalence of Possible Rem Sleep without Atonia in the General Population: Insights from the São Paulo Epidemiologic Sleep Study (EPISONO). Neuroepidemiology. 2026. doi: 10.1159/000545499. PMID: 40139175.
2. Feemster JC, Gossard TR, Bliwise DL, et al. Normative isolated REM sleep without atonia in adults without REM sleep behavior disorder. Sleep. 2019;42(11):zsz158. doi: 10.1093/sleep/zsz158.
3. Högl B, Stefani A, Videnovic A. Idiopathic REM sleep behaviour disorder and neurodegeneration — an update. Nat Rev Neurol. 2018;14(1):40-55. doi: 10.1038/nrneurol.2017.157.
4. Dauvilliers Y, Schenck CH, Postuma RB, et al. REM sleep behaviour disorder. Nat Rev Dis Primers. 2018;4(1):19. doi: 10.1038/s41572-018-0016-5.